Your Blood Tests Came Back Normal. Could You Still Have Lung Cancer?
Routine blood work and annual physicals provide valuable health information. But neither is designed to rule out lung cancer. Here’s what patients should know.
Your annual checkup is finished. Your doctor reviews your blood work and tells you everything looks normal.
For many people, that’s reassuring news. Blood tests can identify important health concerns, and a routine examination offers an opportunity to discuss changes in your health.
But there’s something those results cannot tell you: whether you have lung cancer.
Normal blood work does not rule out lung cancer because standard laboratory tests are not designed to detect it.
Understanding that distinction matters, particularly for people experiencing persistent symptoms or wondering whether they should be screened.
What your routine blood tests actually measure
Two common laboratory tests are the complete blood count (CBC) and comprehensive metabolic panel (CMP).
A CBC measures red blood cells, white blood cells, hemoglobin and platelets. It can help identify anemia, infections and certain blood disorders.
A CMP evaluates substances associated with kidney and liver function, blood sugar, electrolytes and other aspects of health.
Neither test directly examines the lungs for tumors.
Some cancers can produce abnormalities in blood counts or organ-function tests. But those changes have many possible causes and cannot independently establish a lung cancer diagnosis.
The reverse is equally important: Someone can have lung cancer while routine blood results remain within normal ranges.
That does not make annual blood work unnecessary. It means patients should understand what their tests were intended to measure.
Can a doctor detect lung cancer during a physical?
A clinician may listen to your breathing, ask about coughing or shortness of breath, and examine you for signs of illness.
These steps can identify problems that deserve further investigation.
However, a normal physical examination cannot reliably exclude lung cancer, particularly when a tumor is small or produces no noticeable symptoms.
Lung cancer often causes no symptoms in its early stages.
When symptoms do occur, they can include a persistent or changing cough, coughing up blood, chest discomfort, unexplained weight loss, breathing difficulties or repeated respiratory infections.
These symptoms frequently have causes other than cancer. But persistent or worsening changes deserve medical attention even when previous laboratory results were normal.
How is lung cancer detected early?
For people without symptoms who meet established risk criteria, the recommended screening method is a low-dose computed tomography scan, commonly called low-dose CT or LDCT.
Unlike routine blood work, this imaging test creates detailed pictures of the lungs that can reveal suspicious abnormalities.
Under U.S. Preventive Services Task Force recommendations, annual LDCT screening is recommended for adults who:
- Are between 50 and 80 years old.
- Have a smoking history of at least 20 pack-years.
- Currently smoke or stopped smoking within the past 15 years.
A pack-year means smoking an average of one pack of cigarettes daily for one year.
The American Cancer Society also recommends screening for eligible adults ages 50 to 80 with at least 20 pack-years, but does not use the 15-year quitting limit.
Screening has potential harms, including false-positive findings, radiation exposure and unnecessary follow-up procedures. Patients should discuss eligibility and individual circumstances with their healthcare professional.
Screening is for people without symptoms. Someone with concerning symptoms may need diagnostic evaluation regardless of whether they meet routine screening criteria.
What about newer blood tests that look for cancer?
Newer technologies, including multicancer detection blood tests such as Galleri, attempt to identify biological signals associated with different cancers.
They are different from routine CBC or metabolic panels.
However, the National Cancer Institute says these tests have not received FDA authorization for cancer screening, and researchers have not yet established whether their use reduces cancer deaths.
A positive result requires additional testing. A negative result cannot guarantee that cancer is absent.
These technologies should not replace recommended lung cancer screening or appropriate evaluation of symptoms.
What should you ask at your next appointment?
If you are concerned about lung cancer, begin by explaining your symptoms and risk factors rather than requesting a particular test.
Tell your clinician about persistent coughing, breathing changes, unexplained weight loss, coughing up blood or recurring infections.
Discuss your smoking history, including when you quit, as well as relevant exposures such as radon, asbestos or secondhand smoke.
You can also ask:
“Do my symptoms or risk factors suggest I need additional evaluation, even though my blood tests were normal?”
If you cough up blood, seek prompt medical attention. Sudden severe chest pain or serious difficulty breathing requires emergency care.
A normal annual checkup can be good news. It simply does not answer every possible medical question.
The goal is not to test everyone for everything. It is to make sure the right questions lead to the right tests.